World Journal of Clinical Cases - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 35

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

202

WORD

HTML

1750

Figures (1-4)

474

Sum=2447

Publishing Process of This Article

Item

Count

Browse

308

Download

1141

Sum=1449

Dec 16, 2023 (publication date) through May 2, 2026

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Wu RT, Zhang JC, Fang CN, Qi XY, Qiao JF, Li P, Su L. Anlotinib in combination with pembrolizumab for low-grade myofibroblastic sarcoma of the pancreas: A case report. World J Clin Cases 2023; 11(35): 8385-8391 [PMID: 38130609 DOI: 10.12998/wjcc.v11.i35.8385]
URL:	https://www.wjgnet.com/2307-8960/full/v11/i35/8385.htm

Number	Citing Articles
1	Juan Lang, Zhongkui Xiong. Significant increase in calcification and ossification observed after the second relapse of low-grade myofibroblast sarcoma treated with radiotherapy followed by anlotinib and toripalimab: a case report. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1606825
2	Maximus C.F. Yeung, Horace M.H. Cheung, Anthony P.Y. Liu, Tony W.H. Shek. Low-grade Myofibroblastic Sarcoma Represents An Epigenetically Distinct Myofibroblastic Tumor With USP6 Upregulation and Stable Genome. Modern Pathology 2026; : 100998 doi: 10.1016/j.modpat.2026.100998